Dublin, April 14, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Cartridges Market - Forecasts from 2025 to 2030" report has been added to ResearchAndMarkets.com's offering.
The global pharmaceutical cartridge market is expected to grow at a CAGR of 3.23% over the forecast period to reach a total market size of US$3.265 billion by 2030, increasing from US$2.785 billion in 2025.
The pharmaceutical cartridge market is poised for robust growth, driven by escalating demand for contamination-resistant drug packaging solutions and the expanding pharmaceutical sector. Key factors fueling this expansion include the rising global burden of chronic diseases, particularly diabetes, which amplifies the need for insulin delivery systems utilizing pre-fillable cartridges.
An aging population, coupled with age-related health conditions, further accelerates market demand. Cartridges are integral to modern drug delivery mechanisms, and their application extends beyond pharmaceuticals to biomedical research and biotechnology, creating additional growth avenues.
Market Drivers
- Diabetes Epidemic: The surge in insulin-dependent diabetes (types 1 and 2) is a primary growth catalyst. In the U.S., over 38 million people live with diabetes (2023 data), with 5%-10% diagnosed with type 1 diabetes (ADA). Globally, diabetes affects approximately 830 million people (WHO, 2022), contributing to severe complications such as cardiovascular disease, kidney failure, and blindness. By 2045, cases are projected to reach 628.6 million (IDF), necessitating advanced insulin delivery solutions like cartridges.
- Aging Population: Age-related chronic diseases and rising healthcare needs among the elderly bolster demand for reliable drug delivery systems.
- Biotech Advancements: Expanding biomedical research and biotech innovation drive cartridge adoption in non-pharmaceutical sectors.
Geographical Trends
- North America: The U.S. dominates the market, supported by high healthcare spending and a mature pharmaceutical industry.
- Asia-Pacific: Emerging as the fastest-growing region, India and China lead due to soaring diabetes rates and healthcare investments. India's healthcare sector reached $372 billion in 2023 (IBEF), with ASEAN nations also contributing to regional growth.
Future Outlook
The convergence of chronic disease prevalence, aging demographics, and biotech advancements positions cartridges as critical components in global healthcare. With diabetes-related mortality claiming 4 million lives annually (IDF), innovations in drug delivery systems will remain pivotal, ensuring sustained market expansion across North America and high-growth Asian economies.
Report Coverage:
- Historical data & forecasts from 2022 to 2030
- Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
- Competitive Positioning, Strategies, and Market Share Analysis
- Revenue Growth and Forecast Assessment of segments and regions including countries
- Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 130 |
| Forecast Period | 2025 - 2030 |
| Estimated Market Value (USD) in 2025 | $2.79 Billion |
| Forecasted Market Value (USD) by 2030 | $3.27 Billion |
| Compound Annual Growth Rate | 3.2% |
| Regions Covered | Global |
Key Topics Covered:
1. INTRODUCTION
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
3.1. Key Findings
3.2. Analyst View
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter's Five Forces Analysis
4.4. Industry Value Chain Analysis
5. GLOBAL PHARMACEUTICAL CARTRIDGE MARKET BY MATERIAL
5.1. Introduction
5.2. Glass
5.3. Plastic
6. GLOBAL PHARMACEUTICAL CARTRIDGE MARKET BY CARTRIDGE SIZE
6.1. Introduction
6.2. Less than 3ml
6.3. 3ml to 5ml
6.4. 5ml to 10ml
6.5. Greater than 10ml
7. GLOBAL PHARMACEUTICAL CARTRIDGE MARKET BY END-USER
7.1. Introduction
7.2. Pharmaceutical Company
7.3. Biotech Company
7.4. Biomedical Research Organization
8. GLOBAL PHARMACEUTICAL CARTRIDGE MARKET BY GEOGRAPHY
8.1. Global Overview
8.2. North America
8.2.1. United States
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Rest of South America
8.4. Europe
8.4.1. United Kingdom
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Rest of Europe
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. United Arab Emirates
8.5.3. Rest of the Middle East and Africa
8.6. Asia-Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Taiwan
8.6.6. Thailand
8.6.7. Indonesia
8.6.8. Rest of Asia-Pacific
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrativeness
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
- Gerresheimer
- Stevanato Group
- SCHOTT AG
- West Pharmaceutical Services, Inc.
- Transcoject GmbH
- Sigma-Aldrich, Inc.
- Nipro Corporation
- Datwyler Holding Inc.
- Shandong Province Medicinal Glass Co., Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/3lr8mb
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
